- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
vTv Therapeutics Inc (VTVT)
vTv Therapeutics Inc stock price live, this page displays NASDAQ VTVT stock exchange data. View the VTVT premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the vTv Therapeutics Inc real time stock price chart below.
What Is the vTv Therapeutics Inc Stock Price Today?
The vTv Therapeutics Inc stock price today is 15.250.
What Is the Stock Symbol for vTv Therapeutics Inc?
The stock symbol for vTv Therapeutics Inc is ""VTVT.""
What Stock Exchange Does vTv Therapeutics Inc Trade On?
vTv Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is vTv Therapeutics Inc a Good Stock to Buy?
Determining whether vTv Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the VTVT quote. (ISIN: US9183852048)
What Is the vTv Therapeutics Inc Stock Price Today?
The vTv Therapeutics Inc stock price today is 15.250.
What Is the Stock Symbol for vTv Therapeutics Inc?
The stock symbol for vTv Therapeutics Inc is ""VTVT.""
What Stock Exchange Does vTv Therapeutics Inc Trade On?
vTv Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is vTv Therapeutics Inc a Good Stock to Buy?
Determining whether vTv Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the VTVT quote. (ISIN: US9183852048)
NASDAQ
Currency in USD
15.250
+0.350(+2.35%)
Real-time Data·
Fair Value
An estimate of a vTv Therapeutics Inc's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
15.200
15.250
52 wk Range
12.620
26.990
VTVT Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
VTVT is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a vTv Therapeutics Inc's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
15.20015.250
52 wk Range
12.62026.990
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
VTVT Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a vTv Therapeutics Inc's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Strong Buy
Price Target
35.500
Upside
+132.79%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
- vTv Therapeutics advances type 1 diabetes trial
- Investing.com
- vTv Therapeutics appoints new CFO amid Phase 3 trial
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Buy
Moving Averages
Sell
vTv Therapeutics Inc Company Profile
vTv Therapeutics Inc., a clinical stage biopharmaceutical company, focuses on the development of orally administered treatments for metabolic and inflammatory diseases. The company’s lead drug candidate is cadisegliatin (TTP399), an orally administered small molecule and liver-selective glucokinase activator that is in Phase III clinical trial to treat type 1 diabetes; and TTP273, an orally available small molecule glucagon-like peptide 1 receptor agonists that is in Phase I clinical trial for the treatment of postprandial hyperglycemia in cystic fibrosis related diabetes patients, as well as in Phase II trial for the treatment of type 2 diabetes. It is also developing HPP737, an orally administered non- central nervous system penetrant PDE4 inhibitor that has completed Phase 1 trials for the treatment of inflammatory diseases. In addition, the company’s other programs include HPP3033, a non-electrophilic therapeutic approach to activating the nuclear factor erythroid 2–related factor 2 (Nrf2) pathway for the treatment of chronic diseases associated with oxidative stress. It has a license agreement Newsoara Biopharma Co., Ltd. o develop and commercialize phosphodiesterase type 4 inhibitors program, including the compound HPP737. The company was incorporated in 2015 and is headquartered in High Point, North Carolina. vTv Therapeutics Inc. is a subsidiary of MacAndrews & Forbes Group LLC.
Compare VTVT to Peers and Sector
Metrics to compare | VTVT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipVTVTPeersSector | |
|---|---|---|---|---|
P/E Ratio | −5.1x | −4.2x | −0.6x | |
PEG Ratio | 0.15 | 0.05 | 0.00 | |
Price/Book | 39.6x | 1.2x | 2.6x | |
Price / LTM Sales | 6,427.6x | 21.4x | 3.3x | |
Upside (Analyst Target) | 138.3% | 105.5% | 40.1% | |
Fair Value Upside | Unlock | −11.0% | 5.3% | Unlock |
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 35.500
(+132.79% Upside)
Earnings
Latest Release
Aug 12, 2025
EPS / Forecast
-0.92 / -1.12
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Stock Exchange Does vTv Therapeutics Inc Trade On?
vTv Therapeutics Inc is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for vTv Therapeutics Inc?
The stock symbol for vTv Therapeutics Inc is "VTVT."
What Is the vTv Therapeutics Inc Market Cap?
As of today, vTv Therapeutics Inc market cap is 109.27M.
What Is vTv Therapeutics Inc's Earnings Per Share (TTM)?
The vTv Therapeutics Inc EPS (TTM) is -7.47.
From a Technical Analysis Perspective, Is VTVT a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has vTv Therapeutics Inc Stock Split?
vTv Therapeutics Inc has split 1 times.
How Many Employees Does vTv Therapeutics Inc Have?
vTv Therapeutics Inc has 23 employees.
What is the current trading status of vTv Therapeutics Inc (VTVT)?
As of 20 Aug 2025, vTv Therapeutics Inc (VTVT) is trading at a price of 15.25, with a previous close of 14.90. The stock has fluctuated within a day range of 15.20 to 15.25, while its 52-week range spans from 12.62 to 26.99.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.